Nutex Health Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Nutex Health Inc.

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for failing to disclose fraudulent activities by its third-party arbitration vendor, HaloMD, which has raised concerns about the legitimacy of the company's reported revenues and financial health [1][2][3]. Group 1: Allegations and Concerns - The lawsuit alleges that Nutex Health Inc. did not disclose that HaloMD was involved in a scheme to defraud insurance companies, leading to unsustainable revenue from arbitration results [2]. - It is claimed that Nutex overstated its ability to remediate internal control weaknesses over financial reporting, affecting the accounting of stock-based compensation obligations [2]. - Blue Orca Capital's short report raised alarms about Nutex's 20-fold share price increase, attributing it to inflated billing practices by HaloMD, which could lead to a collapse in financial performance if these practices cease [3]. Group 2: Financial Impact - Following the announcement of a delay in filing quarterly financial statements due to incomplete accounting adjustments, Nutex's stock price dropped over 16% [4]. - The allegations suggest that if the fraudulent revenue streams are cut off, Nutex's stock could revert to penny-stock levels, indicating a significant risk to investors [3]. Group 3: Legal Proceedings - Shareholders are encouraged to participate in the class action lawsuit, with options to serve as lead plaintiff or remain as absent class members [5]. - Robbins LLP, the law firm handling the case, operates on a contingency fee basis, meaning shareholders incur no fees unless a recovery is achieved [6].